Recent research has also shown that inhibiting the DKK1 transmembrane receptor, KREMEN1 (Krm1), using miR-431 prevents Aβ-mediated synapse loss in corticohippocampal cells taken from transgenic AD mice [71]. This evidence concerns the gene KREMEN1 and Alzheimer disease.